Patent intelligence · AU
AU 2019328599
Compounds and methods for treating fungal infections
Compounds and methods for treating fungal infections
Patent details — AU 2019328599
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Apr 22, 2021
- Expiration
- Apr 17, 2041
- CPC classes
- A61K 38/ 06 A I, A61K/314402, A61K/314427, A61K/31444
Quick answer
AU 2019328599 (Compounds and methods for treating fungal infections) is held by BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH]. Status: granted. Granted Apr 22, 2021. Expires Apr 17, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 38/ 06 A I, A61K/314402, A61K/314427, A61K/31444, A61K/31661, A61K/31675
More from BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH]
Related pharmaceutical patents in our USPTO index.
-
AU 2024384453
CITRATE COORDINATION COMPLEX OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
PT 3886798
COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
granted -
US 20260042800
ANTIMICROBIAL PEPTIDOMIMETICS
granted -
WO 2025114603
COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
granted -
WO 2024094329
PRÉPARATION DE CAPSULE SOUS EMBALLAGE COQUE CONTENANT DU SULFATE D'ISAVUCONAZONIUM
granted -
CA 3268414
MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS
granted -
AU 2022323463
ANTIMICROBIAL PEPTIDOMIMETICS
granted -
AR 127448
DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER
granted
Frequently asked questions
What is US patent 2019328599?
AU 2019328599 (Compounds and methods for treating fungal infections) is held by BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH]. Status: granted. Granted Apr 22, 2021. Expires Apr 17, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2019328599?
BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does AU 2019328599 expire?
Our index shows an expiration date of Apr 17, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.